Search

Champions Oncology Inc

Lezárt

SzektorEgészségügy

4.88 -0.41

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

4.76

Maximum

4.98

Fő mutatók

By Trading Economics

Bevétel

-389K

-667K

Értékesítés

-2.7M

14M

P/E

Szektor átlag

35.118

57.371

Egy részvényre jutó nyereség

-0.05

Profit margin

-4.821

Munkavállalók

214

EBITDA

-278K

-174K

Osztalékok

By Acuity

Következő eredményjelentés

2026. szept. 11.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-15M

70M

Előző nyitás

5.29

Előző zárás

4.88

Hangulat hírek alapján

By Acuity

50%

50%

150 / 340 Rangsor szerint Healthcare

Champions Oncology Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 24. 20:06 UTC

News

Champions Oncology reports gross revenue of $59.42 million, with shares declining since Friday's close despite an earlier session increase.

2026. aug. 21. 20:06 UTC

Champions Oncology Inc shares are lower in Friday's session amid broader market declines, with no specific news identified to explain the volatility.

2026. aug. 20. 19:31 UTC

Champions Oncology Inc is higher today, driven by gains in the Life Sciences Tools & Services sub-sector, despite earlier session declines.

2026. aug. 19. 20:02 UTC

Champions Oncology Inc shares declined during Wednesday's session, reaching a low in late morning amid no specific news to explain the downturn.

2026. aug. 18. 19:41 UTC

Champions Oncology Inc shares are higher today, despite no specific news. Broader market concerns include inflation and rising treasury yields affecting investor sentiment.

2026. aug. 17. 19:36 UTC

Champions Oncology Inc's shares are higher during Monday's session, reflecting a modest increase since Friday's close. The stock remains below its 20-day moving average.

2026. aug. 14. 20:02 UTC

Champions Oncology is trading lower, reflecting broader market sentiment amid a surprising decline in U.S. retail sales for July.

2026. aug. 13. 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

2026. aug. 12. 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

2026. aug. 11. 19:41 UTC

Champions Oncology Inc shares are lower today amid no specific news. The stock remains below its 20-day moving average and near the month's low.

2026. aug. 10. 19:31 UTC

Champions Oncology Inc shares are lower, continuing a decline since Friday's close. The stock remains near its one-month range's lower end.

2026. aug. 7. 19:42 UTC

Champions Oncology Inc shares are higher, driven by gains in the Life Sciences Tools & Services sub-sector. Earlier, they pulled back from a session high.

2026. aug. 6. 19:32 UTC

Champions Oncology Inc shares are lower, continuing a downward trend amid broader market concerns over inflation and Federal Reserve policy. No specific news was identified.

2026. aug. 5. 19:31 UTC

Champions Oncology Inc shares are lower during Wednesday's session, reflecting significant volatility amid broader market conditions and a notable drop in crude oil prices.

2026. aug. 4. 19:51 UTC

Champions Oncology Inc shares are lower today, influenced by a decline in the Life Sciences Tools & Services sub-sector. The stock remains below its 20-day moving average.

2026. aug. 3. 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

2026. júl. 31. 19:46 UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

2026. júl. 30. 17:16 UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

2026. júl. 29. 19:02 UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

2026. júl. 28. 19:32 UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

2026. júl. 27. 23:01 UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

2026. júl. 24. 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

2026. júl. 22. 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Társak összehasonlítása

Árváltozás

Champions Oncology Inc Előrejelzés

Értékelési konszenzus

By TipRanks

0 ratings

0

Vétel

0

Tartás

0

Eladás

Hangulat

By Acuity

150 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat